Nike an Innovation Company at Heart: Poser

Oct. 9 (Bloomberg) -- Sam Poser, analyst at Sterne Agee, talks with Stephanie Ruhle about Nike’s ability to innovate while constantly moving its brand forward and how it stacks up to its competition. He speaks on Bloomberg Television’s “Market Makers.”
Ex-Allergan CEO Converted Stock Holdings for $534M Cash
37:57 - Bloomberg’s Scarlet Fu reports on Ex-Allergan CEO David Pyott trading his stock holdings for five hundred thirty four million dollars in cash on “Money Clip.” (Source: Bloomberg)
  • Indiana Gov. Pence Vows to Fix RFRA Law
  • Matcha Tea: The Ultimate Superfood
  • Options Update: How to Play IBB